Compound information
- Natural Products
- ZC3501398
- Molecular Formula
- C33H35N3O6S
- Molecular Weight
- 601.22465684 g/mol
- Structure
-
- IUPAC Name
- (2R)-6-[[5-(dimethylamino)-1-naphthyl]sulfonylamino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
- InChI
- InChI=1S/C33H35N3O6S/c1-36(2)30-18-9-16-27-26(30)15-10-19-31(27)43(40,41)34-20-8-7-17-29(32(37)38)35-33(39)42-21-28-24-13-5-3-11-22(24)23-12-4-6-14-25(23)28/h3-6,9-16,18-19,28-29,34H,7-8,17,20-21H2,1-2H3,(H,35,39)(H,37,38)/t29-/m1/s1
- InChI Key
- SLBNIPMLSUPCFW-GDLZYMKVSA-N
- SMILES
- CN(C)c1cccc2c(S(=O)(=O)NCCCC[C@@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)cccc12
- Source
- ZINC000103632901
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 43 | Ring Count | 5 |
Heteroatom Count | 10 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 125.04 Å2 | LogP | 5.637 |
LogS | -5.516 | LogD | 3.799 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.006 | Pgp substrate | 1.0 |
HIA | 0.967 | F20 % | 0.908 |
F30 % | 0.608 | Caco-2 | -6.164 |
MDCK | -5.98 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.018 | PPB | 98.489 |
VD | 0.797 | Fu | 1.918 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.214 | CYP1A2 substrate | 0.589 |
CYP2A6 substrate | 0.291 | CYP2B6 substrate | 0.59 |
CYP2C19 inhibitor | 0.441 | CYP2C19 substrate | 0.514 |
CYP2C8 substrate | 0.819 | CYP2C9 inhibitor | 0.768 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.33 |
CYP2D6 substrate | 0.868 | CYP2E1 substrate | 0.282 |
CYP3A4 inhibitor | 0.656 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.114 | CL | 1.606 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.004 | Hepatotoxicity | 0.992 |
Mutagenicity | 0.016 | Rat Oral Acute Toxicity | 0.331 |
FDAMDD | 0.904 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.002 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.122 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.106 | IGC50 | 3.456 |
LC50FM | 3.15 | LC50DM | 2.951 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.457 | NR-AR-LBD | 0.519 |
NR-AhR | 0.696 | NR-Aromatase | 0.301 |
NR-ER | 0.578 | NR-ER-LBD | 0.629 |
NR-PPAR-gamma | 0.956 | SR-ARE | 0.838 |
SR-ATAD5 | 0.663 | SR-HSE | 0.047 |
SR-MMP | 0.247 | SR-p53 | 0.538 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.